Acellular implantable and injectable hydrogels for vascular regeneration

Biomedical Materials (Bristol)

Volumn 10, Issue 3, 2015, Pages

  Blatchley, Michael R ^a,b   Gerecht, Sharon ^a,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Johns Hopkins University   (United States)

^c Johns Hopkins University   (United States)

Author keywords

angiogenesis; hydrogel; regenerative medicine; tissue engineering; vasculogenesis

Indexed keywords

DESIGN; DISEASES; STIFFNESS MATRIX; TISSUE ENGINEERING;

ANGIOGENESIS; ANGIOGENIC GROWTH FACTORS; CORONARY ARTERY DISEASE; MICROENVIRONMENTAL FACTORS; PERIPHERAL ARTERY DISEASE; REGENERATIVE MEDICINE; THERAPEUTIC ANGIOGENESIS; VASCULOGENESIS;

HYDROGELS;

BIOLOGICAL FACTOR; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; HYDROGEL;

ANGIOGENESIS; CONJUGATION; DEGRADATION; ENCAPSULATION; HUMAN; HYDROGEL; HYPEROXIA; HYPOXIA; MICROENVIRONMENT; MORPHOGENESIS; NONHUMAN; REVIEW; THERAPY EFFECT; TISSUE ENGINEERING; TISSUE REGENERATION; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD VESSEL; CELL FREE SYSTEM; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; INJECTION; PHYSIOLOGY; REGENERATION; TISSUE SCAFFOLD;

ANIMALS; BLOOD VESSELS; CELL-FREE SYSTEM; HUMANS; HYDROGELS; INJECTIONS; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; TISSUE SCAFFOLDS;

EID: 84933051716     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/10/3/034001     Document Type: Review

References (104)

1. Carmeliet P and Jain R K 2000 Angiogenesis in cancer and other diseases Nature 407 249-57
2. Carmeliet P and Jain R K 2011 Molecular mechanisms and clinical applications of angiogenesis Nature 473 298-307
3. Risau W 1997 Mechanisms of angiogenesis Nature 386 671-4
4. Hanjaya-Putra D et al 2011 Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix Blood 118 804-15
5. Kamei M et al 2006 Endothelial tubes assemble from intracellular vacuoles in vivo Nature 442 453-6
6. Davis G E and Senger D R 2005 Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization Circ. Res. 97 1093-107
7. Davis G E and Camarillo C W 1996 An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in 3D collagen matrix Exp. Cell Res. 224 39-51
8. Bayless K J, Salazar R and Davis G E 2000 RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in 3D fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins Am. J. Pathol. 156 1673-83
9. Lee S et al 2007 Autocrine VEGF signaling is required for vascular homeostasis Cell 130 691-703
10. Phng L K and Gerhardt H 2009 Angiogenesis: a team effort coordinated by notch Dev. Cell 16 196-208
11. Augustin H G et al 2009 Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system Nat. Rev. Mol. Cell Biol. 10 165-77
12. Saharinen P et al 2008 Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts Nat. Cell Biol. 10 527-37
13. Beenken A and Mohammadi M 2009 The FGF family: biology, pathophysiology and therapy Nat. Rev. Drug Discovery 8 235-53
14. Kalluri R 2003 Basement membranes: structure, assembly and role in tumour angiogenesis Nat. Rev. Cancer 3 422-33
15. Semenza G L 2012 Hypoxia-inducible factors in physiology and medicine Cell 148 399-408
16. Bergers G et al 2000 Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nat. Cell Biol. 2 737-44
17. Rundhaug J E 2005 Matrix metalloproteinases and angiogenesis J. Cell. Mol. Med. 9 267-85
18. Tvorogov D et al 2010 Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization Cancer Cell 18 630-40
19. Phng L K et al 2009 Nrarp coordinates endothelial notch and Wnt signaling to control vessel density in angiogenesis Dev. Cell 16 70-82
20. Carmeliet P et al 2001 Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nat. Med. 7 575-83
21. Jain R K 2003 Molecular regulation of vessel maturation Nat. Med. 9 685-93
22. Foo S S et al 2006 Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly Cell 124 161-73
23. Gaengel K et al 2009 Endothelial-mural cell signaling in vascular development and angiogenesis Arterioscler. Thromb. Vasc. Biol. 29 630-8
24. Lutolf M P and Hubbell J A 2005 Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering Nat. Biotechnol. 23 47-55
25. Lee K Y and Mooney D J 2001 Hydrogels for tissue engineering Chem. Rev. 101 1869-79
26. Slaughter B V et al 2009 Hydrogels in regenerative medicine Adv. Mater. 21 3307-29
27. Park K M and Gerecht S 2014 Harnessing developmental processes for vascular engineering and regeneration Development 141 2760-9
28. Rafii S and Lyden D 2003 Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration Nat. Med. 9 702-12
29. Kusuma S and Gerecht S 2010 Engineering blood vessels using stem cells: innovative approaches to treat vascular disorders Expert Rev. Cardiovasc. Therapy 8 1433-45
30. Sieveking D P and Ng M K C 2009 Cell therapies for therapeutic angiogenesis: back to the bench Vasc. Med. 14 153-66
31. Gupta R, Tongers J and Losordo D W 2009 Human studies of angiogenic gene therapy Circul. Res. 105 724-36
32. Lazarous D F et al 1997 Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution Cardiovasc. Res. 36 78-85
33. Zisch A H et al 2003 Cell-demanded release of VEGF from synthetic, biointeractive cell-ingrowth matrices for vascularized tissue growth Faseb. J. 17 2260
34. Hariawala M D et al 1996 VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts J. Surg. Res. 63 77-82
35. Lee R J et al 2000 VEGF gene delivery to myocardium: deleterious effects of unregulated expression Circulation 102 898-901
36. Silva E A and Mooney D J 2007 Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis J. Thromb. Haemost. 5 590-8
37. Sacchi V et al 2014 Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF(164) Proc. Natl Acad. Sci. USA 111 6952-7
38. Zisch A H et al 2001 Covalently conjugated VEGF-fibrin matrices for endothelialization J. Control. Release 72 101-13
39. Lee J and Lee K Y 2009 Local and sustained vascular endothelial growth factor delivery for angiogenesis using an injectable system Pharmaceut. Res. 26 1739-44
40. Lee J et al 2010 Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system Pharmaceut. Res. 27 767-74
41. DeVolder R, Antoniadou E and Kong H 2013 Enzymatically cross-linked injectable alginate-g-pyrrole hydrogels for neovascularization J. Control. Release 172 30-7
42. des Rieux A et al 2011 3D systems delivering VEGF to promote angiogenesis for tissue engineering J. Control. Release 150 272-8
43. Jeon O et al 2005 Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin J. Control. Release 105 249-59
44. Jeon O et al 2006 Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel Biomaterials 27 1598-607
45. Hosseinkhani H et al 2006 Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration Biomaterials 27 5836-44
46. Saik J E et al 2011 Covalently immobilized platelet-derived growth factor-BB promotes antiogenesis in biomirnetic poly(ethylene glycol) hydrogels Acta Biomater. 7 133-43
47. Phelps E A et al 2010 Bioartificial matrices for therapeutic vascularization Proc. Natl Acad. Sci. USA 107 3323-8
48. Kimura Y and Tabata Y 2010 Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis J. Biomater. Sci.-Polym. Edn 21 37-51
49. Prokoph S et al 2012 Sustained delivery of SDF-1 alpha from heparin-based hydrogels to attract circulating pro-angiogenic cells Biomaterials 33 4792-800
50. Moon J J, Lee S H and West J L 2007 Synthetic biomimetic hydrogels incorporated with Ephrin-A1 for therapeutic angiogenesis Biomacromolecules 8 42-9
51. Saik J E et al 2011 Biomimetic hydrogels with immobilized Ephrin-A1 for therapeutic angiogenesis Biomacromolecules 12 2715-22
52. Wacker B K et al 2006 Delivery of sphingosine 1-phosphate from poly(ethylene glycol) hydrogels Biomacromolecules 7 1335-43
53. Mulyasasmita W et al 2014 Avidity-controlled delivery of angiogenic peptides from injectable molecular-recognition hydrogels Tissue Eng. A 20 2102-14
54. Storrie H and Mooney D J 2006 Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering Adv. Drug Deliv. Rev. 58 500-14
55. Kong H J et al 2008 Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA Pharmaceut. Res. 25 1230-8
56. Shepard J A et al 2012 Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis Biomaterials 33 7412-21
57. Tokatlian T, Cam C and Segura T 2014 Non-viral DNA delivery from porous hyaluronic acid hydrogels in mice Biomaterials 35 825-35
58. Leach J B et al 2003 Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds Biotechnol. Bioeng. 82 578-89
59. Leach J B and Schmidt C E 2005 Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds Biomaterials 26 125-35
60. Pike D B et al 2006 Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF Biomaterials 27 5242-51
61. Hanjaya-Putra D et al 2012 Spatial control of cell-mediated degradation to regulate vasculogenesis and angiogenesis in hyaluronan hydrogels Biomaterials 33 6123-31
62. Huang C C et al 2014 3D self-assembling leucine zipper hydrogel with tunable properties for tissue engineering Biomaterials 35 5316-26
63. Purcell B P et al 2014 Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition Nat. Mater. 13 653-61
64. Peattie R A et al 2004 Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants Biomaterials 25 2789-98
65. Zieris A et al 2011 Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels J. Control. Release 156 28-36
66. Chwalek K et al 2014 Glycosaminoglycan-based hydrogels to modulate heterocellular communication in in vitro angiogenesis models Sci. Rep. 4 4414
67. Martino M M et al 2013 Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix Proc. Natl Acad. Sci. USA 110 4563-8
68. Martino M M et al 2014 Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing Science 343 885-8
69. Zhang H et al 2013 Dual-delivery of VEGF and PDGF by double-layered electrospun membranes for blood vessel regeneration Biomaterials 34 2202-12
70. Cao L et al 2009 Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling Biomaterials 30 4085-93
71. Chen C S et al 1998 Micropatterned surfaces for control of cell shape, position, and function Biotechnol. Prog. 14 356-63
72. Dike L E et al 1999 Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates In Vitro Cell. Dev. Biol.-Animal 35 441-8
73. Moon J J et al 2009 Micropatterning of Poly(Ethylene Glycol) diacrylate hydrogels with biomolecules to regulate and guide endothelial morphogenesis Tissue Eng. A 15 579-85
74. Raghavan S et al 2010 Geometrically controlled endothelial tubulogenesis in micropatterned gels Tissue Eng. A 16 2255-63
75. Chang C C et al 2012 Determinants of microvascular network topologies in implanted neovasculatures Arterioscler. Thromb. Vasc. Biol. 32 5-U55
76. Chiu Y C et al 2011 The role of pore size on vascularization and tissue remodeling in PEG hydrogels Biomaterials 32 6045-51
77. Artel A et al 2011 An agent-based model for the investigation of neovascularization within porous scaffolds Tissue Eng. A 17 2133-41
78. Lutolf M P et al 2003 Cell-responsive synthetic hydrogels Adv. Mater. 15 888
79. Miller J S et al 2010 Bioactive hydrogels made from step-growth derived PEG-peptide macromers Biomaterials 31 3736-43
80. Zieris A et al 2010 FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis Biomaterials 31 7985-94
81. Yee D et al 2011 Hyaluronic acid hydrogels support cord-like structures from endothelial colony-forming cells Tissue Eng. A 17 1351-61
82. Rao R R et al 2012 Matrix composition regulates 3D network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials Angiogenesis 15 253-64
83. Wu Y, Al-Ameen M A and Ghosh G 2014 Integrated effects of matrix mechanics and vascular endothelial growth factor (VEGF) on capillary sprouting Ann. Biomed. Eng. 42 1024-36
84. Sun G et al 2011 Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors Biomaterials 32 95-106
85. Forget A et al 2013 Polysaccharide hydrogels with tunable stiffness and provasculogenic properties via alpha-helix to beta-sheet switch in secondary structure Proc. Natl Acad. Sci. USA 110 12887-92
86. Pugh C W and Ratcliffe P J 2003 Regulation of angiogenesis by hypoxia: role of the HIF system Nat. Med. 9 677-84
87. Simon M C and Keith B 2008 The role of oxygen availability in embryonic development and stem cell function Nat. Rev. Mol. Cell Biol. 9 285-96
88. Park K M and Gerecht S 2014 Hypoxia-inducible hydrogels Nat. Commun. 5 4075
89. Park K M, Blatchley M R and Gerecht S 2014 The design of dextran-based hypoxia-inducible hydrogels via in situ oxygen-consuming reaction Macromol. Rapid Commun. 35 1968-75
90. Ushio-Fukai M and Alexander R W 2004 Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase Mol. Cell. Biochem. 264 85-97
91. Ushio-Fukai M and Nakamura Y 2008 Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy Cancer Lett. 266 37-52
92. Xu W M et al 2002 The role of nitric oxide in cancer Cell Res. 12 311-20
93. Kvietys P R and Granger D N 2012 Role of reactive oxygen and nitrogen species in the vascular responses to inflammation Free Radical Biol. Med. 52 556-92
94. Dewhirst M W, Cao Y and Moeller B 2008 Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response Nat. Rev. Cancer 8 425-37
95. Thom S R 2011 Hyperbaric oxygen: its mechanisms and efficacy Plast. Reconstruct. Surg. 127 131S-41S
96. Goldman R J 2009 Hyperbaric oxygen therapy for wound healing and limb salvage: a systematic review PM&R 1 471-89
97. Riley C M et al 2006 Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels Biomaterials 27 5935-43
98. Peattie R A et al 2006 Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants Biomaterials 27 1868-75
99. Hosack L W et al 2008 Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels Biomaterials 29 2336-47
100. Shin S H et al 2013 Co-delivery of vascular endothelial growth factor and Angiopoietin-1 using injectable microsphere/hydrogel hybrid systems for therapeutic Angiogenesis Pharmaceut. Res. 30 2157-65
101. Jay S M et al 2010 Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization Biomaterials 31 3054-62
102. Layman H et al 2009 Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model Acta Biomater. 5 230-9
103. Liu Y et al 2006 Application of bFGF and BDNF to improve angiogenesis and cardiac function J. Surg. Res. 136 85-91
104. Matsui M and Tabata Y 2012 Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels Acta Biomater. 8 1792-801